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Abstract	
	
A first generation machine-assisted approach towards the preparation of hybrid 
ligand/metal materials has been explored. A comparison of synthetic approaches 
demonstrates that incorporation of both flow chemistry and microwave heating, can 
be successfully applied to the rapid synthesis of a range of new phenyl-1H-pyrazoles 
(ppz) substituted with electron withdrawing groups (-F, -CF3, -OCF3, -SF5), and 
these, in turn, can be translated in to heteroleptic complexes, [Ir(ppz)2(bipy)]BF4 
(bipy = 2,2’-bipyridine). Microwave-assisted syntheses for the IrIII complexes allows 
isolation of spectroscopically pure species in less than 1 hour of reaction time from 
IrCl3. All new complexes have been explored photophysically (including nanosecond 
time-resolved transient absorption spectroscopy), electrochemically and by TD-DFT 
studies which show that the complexes possess ligand-dependent, and thus, 
tuneable green-yellow luminescence (500-560 nm), with quantum yields in the range 
5-15 %. 
	
Introduction	
	
In recent years, a surge in the use of machine-assisted practice in the synthesis 
laboratory has begun to streamline the discovery and scale-up of organic molecules 
with biological activity, such as pharmaceuticals, agrochemicals, flavours and 
fragrances. [1] The use of robotic microwaves with touchscreen user interfaces and 
continuous flow apparatus has led to systems that can operate un-manned in a 24/7 
regime and deliver results and data to human operators. The recent addition of 
computer control, inline analytics [2] and optimising algorithms [3] has already afforded 
early examples of machines capable of the unassisted optimisation of chemical 
reactions. Further, the addition of automated biological assays into the machine-
assisted discovery loop has now led to a closed-loop machine platform that is 
	 2	
capable of optimising compound potency through iterative synthesis, 
characterisation and screening cycles. [4] Clearly these methods have the potential to 
be extremely powerful and greatly assist in the pursuit of new or improved material 
properties. However, to date there have been few applications of these techniques to 
the area of inorganic synthesis including the preparation of metal complexes. [5] 
Of interest to us is the development of such a machine-assisted approach for the 
preparation of ligand/metal hybrid materials that exhibit tuneable properties (Figure 
1).  Such a technology platform could then be used to design and search for 
materials that have application in a broad range of disciplines [6] including: OLEDs, [7] 
photosensitisers in catalysis (including photoredox), [8] cellular bioimaging, [9] 
piezochromics [10] and as responsive materials for data recording. [11] Often, the fine-
tuning of the physicochemical properties of such complexes lies in the design and 
screening of the organic ligand component. Several strategies are available for 
tuning [12] the luminescent properties of cationic cyclometalated metal complexes, [13] 
but advances in the efficient, rapid and cost-effective synthesis of such species are 
rarely employed and yet highly desirable. Thus, our work herein is represented in 
Figure 1 (A), and considered as the underpinning work for a future machine-assisted 
approach for the synthesis and optimisation of materials properties (B). In addition to 
the current state-of the art process for materials optimization we envisage machine-
assistance would consist of real-time characterization of material properties and 
input of this data into a computer. The computer would offer multiple purposes such 
as, reaction or property optimization through statistical analysis, data storage, and, 
management and direction of the synthetic steps. 
	
	
Figure	1.	This	work:	proof	of	concept,	chemistry	model	validation	and	development	of	
synthesis	machines	1	and	2.	
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For the computer to be able to interface with the synthetic reaction steps of the 
process the reactions should be carried out by a technique that can readily interface 
with computer control. Our first-generation approach towards this goal consists of the 
demonstration of a modular flow/microwave hybrid approach to the synthesis of a 
novel series of ligands, demonstration of a microwave approach to the assembly of 
the complexes and identification of suitable model chemical system with which to 
explore this concept. With regards to the chemistry model, cyclometalated iridium(III) 
complexes have been demonstrated to have a broad range of applications, and 
specifically offer the opportunity as tuneable wavelength phosphors. IrIII complexes 
are particularly interesting around photoredox catalysis. Encouraged by recent work 
which has characterised a modular metal-free process for the preparation of 
pyrazole heterocycles via a vitamin C medicated reduction of diazonium salts, we 
opted to explore a novel series of iridium-pyrazolate materials. [14] 
	
	
Results	and	Discussion	
	
Phenyl-pyrazoles were targeted as ligands with electron withdrawing, fluorine-
containing phenyl substituents that would firstly permit facile C-H 
insertion/cyclometalation following initial coordination of the pyrazole nitrogen to an 
iridium centre. Secondly, the ligand should induce a strong element of electronic 
tuning to the iridium colour centre. A family of such fluorinated pyrazole-iridium 
complexes have not been reported. Enhancing the electron withdrawing capability of 
the coordinating phenyl unit is known to blue shift the emission wavelength of 
luminescent IrIII complexes.[13] Our approach is outlined in Scheme 1 and features 
the input of the appropriately fluorinated aniline(s) into the continuous flow apparatus 
for the ligand synthesis phase. This was followed by a two-step iridium ligation 
process in which both batch and microwave approaches were compared. 
	
	
Scheme	1.	Preparation	of	fluorinated	pyrazole	ligands	using	a	continuous	flow-microwave	
hybrid	approach.	
	
The substituted pyrazoles (ppz-1 to ppz-6) were synthesised from a selected aniline 
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(pentafluorothio)aniline, 3-(pentafluorothio)aniline, 4-fluoroaniline),  which was firstly 
diazotised in the flow reactor (Scheme 2) by combination with a stream of HCl and 
isoamylnitrite, before combination with a further stream that delivered the ascorbic 
acid for reduction to the oxamayl-hydrazide derivative. The formed hydrazine 
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surrogate was then collected in a microwave vial before combining with 
acetylacetone and irradiation at 140 °C for 30 minutes. 
	
Scheme	2.	Summary	of	the	synthetic	routes	to	the	ligands	and	complexes.	
	
The resultant product was purified by aqueous extraction and silica chromatography 
to furnish the fluorous substituted 3,5-dimethyl pyrazoles (ppz-X) in good-to-excellent 
yield. The utilised ‘flow+microwave’ setup is shown schematically in Scheme 2. It 
should be noted that whilst the present study concerns the design and development 
of automatable machines, this chemistry can also be conducted more conventionally 
(batch) in a round-bottom-flask (CAUTION: for the latter approach, where unknown 
diazonium entities are being generated, we would advise small scale reactions given 
the potential for diazoniums to undergo uncontrollable energy release). Thus, the 
flow process for the generation and consumption of diazonium salts affords safety 
benefits as well as versatility and the potential for automation. 
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Scheme	3.	Structures	and	comparison	of	preparative	yields	of	the	substituted	phenyl-
pyrazole	ligands.	
	
These fluorinated pyrazoles (Scheme 3) were then successfully utilised as 
cyclometalating ligands with IrIII, thus delivering six new complexes of the general 
form [Ir(ppz)2(bipy)]BF4. Firstly, the complexes were synthesised by applying well-
known batch chemistry conditions [15] for the dimeric precursors [(ppz)2Ir(µ-
Cl)2Ir(ppz)2] (reaction duration 48 hrs). Each [(ppz)2Ir(µ-Cl)2Ir(ppz)2] compound was 
then reacted with AgBF4 in MeCN (2 hrs) to give the corresponding bis-acetonitrile 
adduct [Ir(ppz)2(MeCN)2]BF4 (Scheme 2), and subsequent reaction with 2,2¢-
bipyridine gave facile conversion (24 hrs) to the mixed-ligand target complexes 
[Ir(ppz)2(bipy)]BF4. The six complexes were isolated as powders of a pale green-
brown colouration. 
	
At this point we assessed the usefulness of a machine approach for the iridium 
chemistry. [16] During the course of our own studies, Stephenson and co-workers 
reported a significant reduction in the reaction times for complex formation using a 
microwave method for the two-step synthesis of cyclometalated IrIII complexes in 
ethylene glycol. [17] Davies and co-workers have described microwave reaction 
conditions using iPrOH as solvent, which successfully gave cyclometalated IrIII dimer 
species. [18] Here the microwave approach was applied to each of the three steps: (i) 
[(ppz)2Ir(µ-Cl)2Ir(ppz)2] from IrCl3 in 2-methoxyethanol for 15 min at 180 °C; (ii) dimer 
cleavage to cis-[Ir(ppz)2(MeCN)2]BF4 achieved in acetonitrile for 10 min at 120 °C; 
(iii) conversion to [Ir(ppz)2(bipy)]BF4 in chloroform for 15 min at 130 °C. Using this 
microwave-assisted approach, the target  [Ir(ppz)2(bipy)]BF4 complexes were much 
more rapidly isolated with total reaction times of < 1 hr. The yields of the target	
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complexes are respectable and directly comparable to conventional methods, where 
74 hrs are required to isolate these species. However, the complexes (Scheme 4) 
are now obtainable within a day, including work-up procedures and purification via 
column chromatography (if required).	
	
	
	
Scheme	4.	Structures,	total	reaction	times	and	comparative	yields	(final	step)	of	the	isolated	
Ir
III
-pyrazolato	complexes.	
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Pleasingly from the perspective of inline analytics, the complexes were reasonably 
soluble in a range of common organic solvents allowing rapid characterization in the 
solution state using 1H, 13C{1H}, IR, high resolution mass spectrometry, UV-vis., 
time-resolved transient absorption and luminescence spectroscopies, as well as 
cyclic voltammetry. Supporting TD-DFT calculations were also used to assist and 
inform the assignments of the electronic transitions noted from experimental 
observations. Confirmation of the solid-state structures were provided through X-ray 
crystallographic studies on two examples. 
	
X-ray crystallographic structural studies 
 
Crystals suitable for X-ray diffraction were obtained by vapour diffusion of diethyl 
ether into concentrated MeCN solutions of the respective complex. In this manner, 
two examples were obtained describing the solid-state structures of [Ir(ppz-
3)2(bipy)]BF4 and [Ir(ppz-6)2(bipy)]BF4 (Figure 2). Data collection parameters are 
shown in Table S1 (ESI), together with supporting bond length (Table S2) and bond 
angle data (Table S3). These structures revealed the anticipated formulations for 
both complexes and demonstrate retention of the different pyrazolato substituents. In 
both cases the cyclometalating units are arranged with the coordinated C atoms in a 
cis arrangement. The bond angles show a distorted octahedral geometry at IrIII in 
both cases. 
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Figure	2.	Molecular	structures	of	the	iridium	complexes	(top:	[Ir(ppz-3)2(bipy)]BF4;	bottom:		
[Ir(ppz-6)2(bipy)]BF4).	Thermal	ellipsoids	drawn	at	the	30%	probability	level.	Hydrogen	
atoms,	anions	and	solvent	molecules	are	omitted	for	clarity.	
	
Density functional theory (DFT) studies 
 
Frontier molecular orbital data for the six IrIII complexes, calculated after full 
geometry optimisation, are reported in Table 1. They show a consistent HOMO-
LUMO gap of around 3 eV with minor changes due to the nature and position of the 
fluorinated substituents on the cyclometalated ligand fragments. This is in broad 
agreement with the electrochemical data discussed later in Table 3, but with a slight 
overestimation. In all cases, the HOMO has mixed iridium 5d (12.5 to 21.9%) and 
pyrazolate p-character, with the –SF5 substituents increasing the Ir contribution, 
while the LUMO is wholly located on the ancillary bipyridine ligand, as shown in 
Figure 3. 
	 9	
	
To probe the spectroscopy of these complexes in more detail, TD-DFT calculations 
were carried out on [Ir(ppz-5)2(bipy)]
+, using the CAM-B3LYP functional. Strong 
singlet transitions were predicted to lie in the range of 270 to 300 nm, the most 
intense of which at 272 nm is dominated by a p-p* transition within the bipyridine 
ligand. Lower energy triplet absorption bands are also predicted at 422 and 388 nm: 
at the scalar relativistic level used for these calculations, such bands are formally 
forbidden with an intensity of exactly zero. The orbital make-up of the 422 nm band 
is complex, with MOs as low as HOMO-16 (metal 5d / bipy p) contributing, but it is 
interesting to note that the predicted dominant contribution is HOMO-6 à LUMO, 
which is also a p-p* transition within bipyridine. This data therefore suggests that the 
shoulder seen in absorption spectra could comprise a 3ILbipy transition, which is 
presumably weakly allowed due to spin-orbit coupling that stems from smaller 
contributions from a 3MLCT transition. TD-DFT was also used to examine emission 
from the geometry optimised lowest triplet excited state of [Ir(ppz-5)2(bipy)]
+. Once 
again, such bands are formally forbidden so no information on intensity is available, 
but this approach predicts emission at 510 nm, again in qualitative agreement with 
the experimental data. However, as with the triplet absorption, this band is 
dominated by intra-ligand transitions within the bipyridine with smaller 3MLCT type 
contributions also noted, the latter a much more likely assignment to the broad 
featureless emission observed in the experiments. 
	
	
	
	
Figure	3.	Isosurface	plots	for	HOMO	(left)	and	LUMO	(right)	of	[Ir(ppz-5)2(bipy)]
+
,	displayed	
at	0.04	au.	
	
	
Electronic and redox properties of the complexes 
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The UV-vis. absorption spectra of the complexes (Figure 4) were obtained on 
aerated acetonitrile solutions and show several common features between 250 and 
450 nm. Ligand-centred (1p-p*) transitions dominate, with high molar absorption 
coefficients, <320 nm. A much weaker feature, present as a shoulder between 400 
and 450 nm is tentatively assigned as a 1MLCT transition with the possibility of a 
spin forbidden 3MLCT also contributing. The position of the MLCT band(s) appear to 
be relatively insensitive to the variations in substituent (nature and position) that are 
present on the cyclometalated pyrazole ligand. Luminescence spectra were obtained 
(Figure 5 and Table 2) on aerated acetonitrile solutions. Using an excitation 
wavelength of 380 nm the complexes revealed a broad featureless emission peak 
that ranged between 510 and 560 nm (Figure 5) depending upon the nature of the 
pyrazole ligand. For comparison, [Ir(ppy)2(bipy)]PF6 (ppy = 2-phenylpyridine) emits at 
602 nm from a mixed 3MLCT/3LLCT excited state; [19] the more closely related 
[Ir(ppz)2(bipy)]PF6 (ppz = 2-phenylpyrazole) emits at 563 nm in MeCN.
 [20] In this 
study, the most red-shifted emission was induced by para-fluorination of the 
cyclometalating ligand in [Ir(ppz-5)2(bipy)]BF4, whilst the blue-shifted variants were 
the pentafluorosulfanyl derivatives [Ir(ppz-4)2(bipy)]BF4 and [Ir(ppz-6)2(bipy)]BF4 
(meta substitution induced the highest energy emission). These lem trends are 
supported by the Ebandgap data from the TD-DFT calculations (Table 1). The data 
suggests that in these complexes the electron withdrawing capacity of -SF5 is 
greater than -CF3, -OCF3 and -F. It is noteworthy that pentafluorosulfanyl-substituted 
[Ir(ppy)2(bipy)]
+ species have recently been shown to possess blue-shifted emission 
properties. [21] Low temperature (77K) spectra revealed a general hypsochromic shift 
in the emission maxima together with stronger vibrational features in the peak 
appearance (Figure 5 inset). The aerated, solution state quantum yields (5-19%) 
were also obtained together with the luminescence lifetimes (Table 2), which lie in 
the range 77-123 ns.  From these values, kr and knr were determined for the different 
complexes (Table 2) and the resultant data shows a clear correlation between the 
energy of the emission maximum and knr (and thus in accordance with the energy 
gap law). Therefore, for these complexes the nature of the emitting state, which we 
attribute to a strong 3MLCT character, is likely to be closely comparable across the 
series. 
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Figure	4.	Comparison	of	the	UV-vis.	spectra	for	the	complexes	(in	MeCN).	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	5.	Main:	Normalised	emission	spectra	of	the	complexes	(MeCN,	lex	=	380	nm).	
Foreground:	emission	spectra	at	77K	(MeOH/EtOH	glass,	lex	=	380	nm).	
	
Transient absorption (TA) spectroscopy was also conducted (using a pump 
wavelength of 266 nm) on the complexes under the same solvent conditions as 
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described above for the UV-vis. and luminescence measurements. The spectral 
appearance of all six samples is very similar (Figure S2, ESI) with a bleach (or 
reduction) in optical density (OD) at l ~ 310 nm and three positive features at l ~ 
380, 490 and 760 nm. Closer inspection of the individual peaks shows very little 
variation in wavelength position across the six complexes. Time-resolved analysis of 
the transient features at l = 380 nm give lifetimes that compare well, both in 
magnitude and trend, to those obtained in the luminescence studies.  
 Analysis of the time-resolved decay of the peaks at l = 760 nm for each 
sample revealed similar lifetimes, each of which correlates reasonably well with their 
respective lifetimes at l = 380 nm. These TA spectral features could, therefore, 
originate from the same excitation and intersystem crossing processes that produce 
the emissive 3MLCT states and, based on the state lifetimes, suggest excited states 
for the series of complexes that are very similar in nature. [22] Careful analysis of the 
features at l = 760 nm suggest that this peak has two underlying components and is 
a doublet. The data is conveniently presented as a 3D contour plot (Figure 6) for 
[Ir(ppz-3)2(bipy)]BF4. Additional TA spectra (including decay fits) are shown in the 
ESI (Figures S2 and S3). 
	
	
	
	
	
Figure	6.	Transient	absorption	spectra	and	data.	Left:	a	3D	time-resolved	plot	for	[Ir(ppz-
3)2(bipy)]BF4.	Right:	fitted	(red	trace)	lifetime	profiles	for	the	different	Ir
III
	complexes.	The	
lowest	panel	shows,	as	an	exemplar,	the	recovery	of	the	spectral	feature	assigned	as	a	
bleach	at	l = 310	nm	for	[Ir(ppz-3)2(bipy)]BF4.	The	recovery	of	the	bleach	occurs	on	a	
timescale	similar	to	the	decay	of	the	absorption	features	at	longer	wavelengths.	
	
The electrochemical characteristics of the six [Ir(ppz)2(bipy)]BF4 complexes (Table 3) 
were studied in de-oxygenated dichloromethane. The cyclic voltammograms were 
measured using a platinum disc electrode (scan rate υ = 200 mV s-1, 1 × 10-3 M 
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solutions, 0.1 M [NBu4][PF6] as a supporting electrolyte) and each complex showed 
one partially or fully reversible oxidation (Table 3) at +1.47 to + 1.75 V) ascribed to 
the IrIII/IV couple. Each complex also showed one partially reversible or irreversible 
reduction wave, which was assigned to a ligand-centred process. The small 
differences in Eox are likely due to the nature of the substituent on the 
cyclometalating ligand that can influence the electron density at the iridium centre. 
For example, [Ir(ppz-5)2(bipy)]BF4 showed the lowest Eox value in the series, 
suggesting that para-fluorination of the pyrazole ligands renders the IrIII more easily 
oxidisable. The pentafluorosulfanyl derived complexes gave the highest oxidation 
potentials. Using the oxidation (IrIII/IV) potential gave the HOMO energy levels 
(EHOMO), from which ELUMO was also determined. The calculated Ebandgap values 
again revealed a lowest value for [Ir(ppz-5)2(bipy)]BF4, with both [Ir(ppz-4)2(bipy)]BF4 
and [Ir(ppz-6)2(bipy)]BF4 at the largest values, which was supported by TD-DFT. 
	
Conclusions 
 
In conclusion, this paper demonstrates a machine-assisted technology for the rapid 
synthesis of luminescent ligand-metal complexes with desirable and tuneable 
photophysical properties. The approach provides improvements on safety, versatility 
and time. From a synthetic perspective, we anticipate that future improvements could 
emanate from connecting the two production phases (ligand and complex) into one 
machine (which would likely require an automated purification phase at the 
connecting junction) and include the ability to automatically screen the luminescent 
properties of the formed products. A third-generation approach could then use 
feedback and optimisation algorithms to deliver a discovery platform for the rapid 
generation of new metal-ligand materials with tuneable and targeted electronic 
properties. Further studies will explore the application of these, and future 
generations of, IrIII complex as photoredox catalysts, as well as considering their 
deployment in bioimaging studies which can exploit the tunability of the 
luminescence properties. 
	
Experimental	
	
General Experimental Considerations 
 
All reagents and solvents were commercially available and were used without further 
purification if not stated otherwise. Petroleum ether refers to the 40-60 °C fraction. For 
the measurement of 1H, 13C and 19F NMR spectra a Bruker Fourier300 (250, 300 MHz), 
400 UltraShieldTM (400 MHz) or AscendTM500 (500 MHz) was used. The obtained 
chemical shifts δ are reported in ppm and are referenced to the residual solvent signal. 
19F NMR signals are reported uncorrected. Spin-spin coupling constants J are given 
in Hz.  
 The flow setup consisted of perfluoroalkoxy (PFA) tubing of an 0.8 mm ID and 
two syringe and two Knauer pumps. The residence coils were made from the tubing 
by taking the appropriate length for the desired volume. The microwave used was a 
CEM Discover SP. Column chromatography was performed using 60 A (40-64 micron) 
silica and solvent mixtures of petroleum ether and ethyl acetate.  
 Low-resolution mass spectra were obtained by the staff at Cardiff University. 
High-resolution mass spectra were carried out at the EPSRC National Mass 
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Spectrometry Facility at Swansea University. High resolution mass spectral (HRMS) 
data were obtained on a Waters MALDI-TOF mx at Cardiff University or on a Thermo 
Scientific LTQ Orbitrap XL by the EPSRC UK National Mass Spectrometry Facility at 
Swansea University. IR spectra were obtained from a Shimadzu IR-Affinity-1S FTIR 
and melting points using a Gallenkamp apparatus and are reported uncorrected. 
Reference to spectroscopic data are given for known compounds. UV-Vis studies 
were performed on a Jasco V-570 spectrophotometer as MeCN solutions (2.5 or 5 × 
10-5 M). Photophysical data were obtained on a JobinYvon–Horiba Fluorolog 
spectrometer fitted with a JY TBX picosecond photodetection module as MeCN 
solutions. Emission spectra were uncorrected and excitation spectra were instrument 
corrected. The pulsed source was a Nano-LED configured for 459 nm output operating 
at 1 MHz. Luminescence lifetime profiles were obtained using the JobinYvon–Horiba 
FluoroHub single photon counting module and the data fits yielded the lifetime values 
using the provided DAS6 deconvolution software. Quantum yield measurements were 
obtained on aerated MeCN solutions of the complexes using [Ru(bpy)3](PF6)2 in 
aerated MeCN as a standard (Φ = 0.016). [23]  
 
X-ray Diffraction  
For both samples, a suitable crystal [24] was selected and mounted on a MITIGEN 
holder in oil on a Rigaku FRE+ (45.0 kV, 55.0 mA) equipped with HF Varimax confocal 
mirrors (100µm focus) and an AFC12 goniometer and HG Saturn 724+ detector 
diffractometer. The crystals were kept at T = 100(2) K during data collection. Data 
were measured using profile data from w-scans using MoKa radiation. Cell 
determination and data collection were carried out using CrystalClear [25]. With the data 
reduction, cell refinement and absorption correction using CrystalisPro [26]. Using 
Olex2 [27], the structures were solved with the ShelXT [28] structure solution program 
and the models were refined with version 2014/7 of ShelXL [29] using Least Squares 
minimisation. All non-hydrogen atoms were refined anisotropically. Hydrogen atom 
positions were calculated geometrically and refined using the riding model. 
 For sample [Ir(ppz-3)2(bpy)]BF4, the BF4 anions are disordered over symmetry 
sites and each contributes half an ion to the asymmetric unit. Also one of the CF3 
groups is disordered over two positions. As such various geometrical (SADI, SAME, 
BUMP) restraints and displacement (RIGU) restraints were employed, along with 
displacement constraints (EADP). 
 For sample [Ir(ppz-6)2(bpy)]BF4, a general displacement restraint (RIGU) has 
been employed due to the number of readily disordered moieties in the asymmetric 
unit. Also there is a molecule of MeCN for which displacement constraints (EADP) 
have been employed. 
 
DFT calculations  
The geometry of all complexes was fully optimised without symmetry constraint using 
the B3LYP [30] functional and a basis set consisting of 6-31G(d) [31] on light atoms with 
Stuttgart-Dresden core potential and basis set on Ir. [32] Frontier orbital properties were 
calculated with the same functional and a 6-31+G(d,p) [33] basis on light atoms. TD-
DFT used the CAM-B3LYP functional [34] known to perform well for charge transfer 
transitions, with 6-31+G(d,p) on light atoms and Stuttgart-Dresden potential/basis on 
Ir. All DFT calculations were performed using the Gaussian09 package. [35] 
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Transient Absorption  
Transient absorption (TA) UV-Vis spectra were collected at Cardiff University using an 
Edinburgh Instruments LP920 laser flash photolysis spectrometer. All spectra were 
generated by exciting the samples (prepared as for UV-Vis studies described above) 
at 266 nm (4th harmonic of a Continuum Surelite II Nd:YAG laser, operated at 10 Hz) 
and collecting subsequent transient absorption spectra between 300 nm < l < 800 
nm (a Xenon lamp provides probe wavelengths). Wavelength dependent TA data was 
recorded in 5 nm steps using an in-built monochromator, with a bandwidth of 1 nm. 
Data presented in this manuscript show early time spectra (t < 1 µs post excitation), 
however no additional TA features were observed over longer timescales (t < 10 ms). 
TA spectra are presented as DODXenon lamp, hereafter simply referred to as DOD, 
constructed by averaging the first 50 ns of data after the pump laser pulse. Lifetime 
data was created by fitting the raw experimental data using the Origin 2015 software 
package. Each fit is created using a single exponential decay function, with no 
evidence for multiexponential components. 
 
Electrochemistry  
Electrochemical studies were carried out using a Parstat 2273 potentiostat in 
conjunction with a three-electrode cell. The auxiliary electrode was a platinum wire 
and the working electrode a platinum (1.0 mm diameter) disc. The reference was a 
silver wire separated from the test solution by a fine porosity frit and an agar bridge 
saturated with KCl. Solutions (10 ml CH2Cl2) were 1.0 × 10
-3 mol dm-3 in the test 
compound and 0.1 mol dm-3 in [NBun4][PF6] as the supporting electrolyte. Under these 
conditions, E0′ for the one-electron oxidation of [Fe(η-C5H5)2], added to the test 
solutions as an internal calibrant, is +0.46 V. [36] Unless specified, all electrochemical 
values are at υ = 200 mV s-1. 
 
Synthesis  
 
General Procedure 1 (GP1): Preparation of fluorinated pyrazole ligands in batch 
and microwave  
 
To a solution of the aniline (3 mmol) in MeCN (5 mL) in a 35 mL microwave vial HCl 
(3 mL, 1 M, 3 mmol, 1 equiv) in water (5 mL) was added. After cooling the solution to 
0 °C isoamylnitrite (0.351 g, 3 mmol, 1 equiv) in MeCN (5 mL) was added dropwise. 
Then ascorbic acid (0.528 g, 3 mmol, 1 equiv) was added neat and another 5 mL water 
added. The solution was stirred for 30 min at room temperature. 2,4-Pentanedione 
(0.600 g, 6 mmol, 2 equiv) was added neat and the reaction solution heated in the 
microwave for 30 min at 140 °C. To the crude reaction mixture was added 10 mL of 
aqueous NaHCO3 before the product was extracted (3 x 25 mL CH2Cl2). The combined 
organic layers were washed with brine (25 mL), dried over MgSO4 and concentrated 
in vacuo to give the crude product. This was further purified via column 
chromatography (0 to 10 % EtOAc in petroleum ether) to yield the product. 
 
Synthesis of 3,5-dimethyl-1-(4-(trifluoromethoxy)phenyl)-1H-pyrazole (ppz-1)  
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Following the general procedure (GP1) with 4-(trifluoromethoxy)aniline (0.503 g, 
3 mmol) the product, 3,5-dimethyl-1-(4-(trifluoromethoxy)phenyl)-1H-pyrazole, was 
obtained as a brown oil (55%, 0.841 g, 3.3 mmol). 1H NMR (400 MHz, CDCl3, 25°C): 
δ= 7.46 (d, J = 7.5 Hz, 2H), 7.29 (d, J = 8.2 Hz, 2H), 6.00 (s, 1H), 2.31 (s, 3H), 2.29 
(s, 3H) ppm; 13C{1H} NMR (126 MHz, CDCl3, 25°C): δ= 149.5, 147.0, 139.5, 138.5, 
126.0, 121.5, 120.5 (q, J = 258 Hz), 107.5, 13.5, 12.5 ppm; 19F NMR (376 MHz, CDCl3, 
25°C): δ= -58.00 (s) ppm; IR: 2928, 1558, 1514, 1252, 1202, 1155, 853 cm-1; HRMS 
(FTMS + p NSI): m/z: 257.0896, calc. 257.0894 for [M+ + H]. 
 
Synthesis of 1-(3-(trifluoromethyl)phenyl)-3,5-dimethyl-1H-pyrazole (ppz-2) 
 
Following the general procedure (GP1) with 3-(trifluoromethyl)aniline (0.483 g, 
3 mmol) the product, 1-(3-(trifluoromethyl)phenyl)-3,5-dimethyl-1H-pyrazole, was 
obtained as a yellow oil (62%, 0.446 g, 1.86 mmol). 1H NMR (500 MHz, CDCl3, 25°C): 
δ= 7.74 (s, 1H), 7.68 – 7.53 (m, 3H), 6.03 (s, 1H), 2.34 (s, 3H), 2.30 (s, 3H) ppm; 
13C{1H} NMR (126 MHz, CDCl3, 25°C): δ= 145.0, 140.5, 139.5, 132.0 (q, J = 32.8 Hz), 
129.5, 127.5, 124.0 (q, J = 3.6 Hz), 123.5 (q, J = 272.5 Hz), 121.5 (q, J = 3.8 Hz), 
108.0, 13.5, 12.5 ppm; 19F NMR (376 MHz, CDCl3, 25°C): δ= -62.68 (s) ppm; IR: 2978, 
1597, 1562, 1497,1454, 1381, 1366, 1327, 1165, 1123, 1069, 895, 799, 698 cm-1; 
HRMS (ASAP+): m/z: 241.0953, calc. 241.0953 for [M+ + H]. 
 
Synthesis of 1-(4-(trifluoromethyl)phenyl)-3,5-dimethyl-1H-pyrazole (ppz-3) 
 
Following the general procedure (GP1) with 4-(trifluoromethyl)aniline (0.483 g, 
3 mmol) the product, 1-(4-(trifluoromethyl)phenyl)-3,5-dimethyl-1H-pyrazole, was 
obtained as a yellow oil (74%, 0.532 g, 2.23 mmol). 1H NMR (400 MHz, CDCl3, 25°C): 
δ= 7.71 (d, J = 8.0 Hz, 2H), 7.59 (d, J = 8.1 Hz, 2H), 6.04 (s, 1H), 2.36 (s, 3H), 2.30 
(s, 3H) ppm; 13C{1H} NMR (126 MHz, CDCl3, 25°C): δ= 150.0, 143.0, 139.5, 129.0 (q, 
J = 32.8 Hz), 126.5 (q, J = 3.5 Hz), 124.5, 124.0 (q, J = 272.0 Hz), 108.5, 13.5, 13.0 
ppm; 19F NMR (376 MHz, CDCl3, 25°C): δ= -62.34 (s) ppm; IR: 2928, 1614, 1321, 
1119, 1067, 843, 457 cm-1; HRMS (FTMS + p NSI): m/z: 241.0947, calc. 241.0944 for 
[M+ + H]. 
 
Synthesis of 1-(3-pentafluorothio)-3,5-dimethyl-1H-pyrazole (ppz-4) 
 
Following the general procedure (GP1) with 3-(pentafluorothio)aniline (0.483 g, 
2 mmol) the product, 1-(3-pentafluorothio)-3,5-dimethyl-1H-pyrazole, was obtained as 
a yellow oil (70%, 0.417 g, 1.4 mmol). 1H NMR (400 MHz, CDCl3, 25°C): δ= 7.87 (s, 
1H), 7.72 (d, J = 8.1 Hz, 1H), 7.62 (d, J = 7.9 Hz, 1H), 7.59 – 7.51 (m, 1H), 6.04 (s, 
1H), 2.34 (s, 3H), 2.30 (s, 3H) ppm; 13C{1H} NMR (101 MHz, CDCl3, 25°C): δ= 150.0, 
140.5, 139.5, 129.5, 127.5, 124.5 – 124.0 (m), 122.5 – 122.0 (m), 108.0, 13.5, 12.5; 
19F NMR (376 MHz, CDCl3, 25°C): δ= 84.42 – 82.41 (m, 1F), 63.24 – 62.43 (m, 4F) 
ppm; IR: 2980, 1605, 1493, 829, 771, 596 cm-1. HRMS (ASAP+): m/z: 299.0664, calc. 
299.0641 for [M+ + H]. 
 
Synthesis of 1-(4-fluorophenyl)-3,5-dimethyl-1H-pyrazole (ppz-5) 
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Following the general procedure with 4-fluoroaniline (0.333 g, 3 mmol) the product, 1-
(4-fluorophenyl)-3,5-dimethyl-1H-pyrazole, was obtained as a yellow oil (57%, 
0.566 g, 2.02 mmol). The spectroscopic data obtained matches the literature.[14a] 1H 
NMR (400 MHz, CDCl3, 25°C): δ= 7.43 – 7.33 (m, 2H), 7.18 – 7.07 (m, 2H), 5.98 (s, 
1H), 2.28 (s, 3H), 2.26 (s, 3H) ppm; 13C{1H} NMR (126 MHz, CDCl3, 25°C): δ= 161.5 
(d, J = 247.0 Hz), 149.0, 139.5, 136.0 (d, J = 2.8 Hz), 127.0 (d, J = 8.6 Hz), 116.0 (d, 
J = 22.8 Hz), 107.0, 13.5, 12.5 ppm; 19F NMR (471 MHz, CDCl3, 25°C): δ= -114 ppm; 
IR: 2924, 1557, 1510, 1383, 1219, 837, 610 cm-1. HRMS (FTMS + p NSI): m/z: 
191.0975, calc. 191.0979 for [M+ + H]. 
 
Synthesis of 1-(4-pentafluorothio)-3,5-dimethyl-1H-pyrazole (ppz-6) 
 
Following the general procedure (GP1) with 4-(pentafluorothio)aniline (0.438 g, 
2 mmol) the product, 1-(4-pentafluorothio)-3,5-dimethyl-1H-pyrazole, was obtained as 
a yellow solid (73%, 0.435 g, 1.46 mmol). The spectroscopic data obtained matches 
the literature.[14a] 1H NMR (400 MHz, CDCl3, 25°C): δ= 7.83 (d, J = 8.4 Hz, 2H), 7.57 
(d, J = 8.6 Hz, 2H), 6.05 (s, 1H), 2.38 (s, 3H), 2.30 (s, 3H) ppm; 13C{1H} NMR (126 
MHz, CDCl3, 25°C): δ= 152.0 – 151.5 (m), 150.5, 142.5, 140.0, 127.5 – 126.5 (m), 
123.5, 108.5, 13.5, 13.0 ppm; 19F NMR (376 MHz, CDCl3, 25°C): δ= 85.17 – 83.13 (m, 
1F), 63.68 – 62.92 (m, 4F) ppm; IR: 2980, 1555, 1503, 1366, 808, 789, 768, 660, 
575 cm-1; HRMS (ASAP+): m/z: 299.0648, calc. 299.0641 for [M+ + H].  
 
General Procedure 2 (GP2): Preparation of fluorinated pyrazole ligands in flow 
and microwave [14a] 
 
Solutions of the aniline (0.2 M in acetonitrile), HCl (0.2 M in water), isoamylnitrite 
(0.2 M in acetonitrile) and ascorbic acid (0.2 M in acetonitrile) were prepared. The 
solutions were then pumped through the flow system (see Scheme S1 and S2) at a 
flow rate of 0.2 mLmin-1. After 20 min steady state was presumed reached and 20 mL 
(1 mmol, 25 min) of the resulting reaction mixture was collected and transferred into a 
microwave vial equipped with a stirrer bar and 2,4-pentadione (0.200 g, 2 mmol, 2 
equiv). The mixture was heated to 140 °C for 30 min in the microwave. After cooling 
to room temperature, the reaction mixture was quenched with 10 mL NaHCO3, 
extracted with CH2Cl2 (3 x 20 mL), washed with brine and dried over MgSO4. After 
removing the solvent under reduced pressure the crude product was further purified 
by column chromatography to give the desired product. 
 
Synthesis of 3,5-dimethyl-1-(4-(trifluoromethoxy)phenyl)-1H-pyrazole (ppz-1) 
 
Following the general procedure (GP2), 3,5-dimethyl-1-(4-(trifluoromethoxy)phenyl)-
1H-pyrazole  was obtained as a brown oil (70%, 0.180 g). 
 
Synthesis of 1-(3-(trifluoromethyl)phenyl)-3,5-dimethyl-1H-pyrazole (ppz-2) 
 
Following the general procedure (GP2), 1-(3-(trifluoromethyl)phenyl)-3,5-dimethyl-1H-
pyrazole was obtained as a yellow oil (48%, 0.116 g). 
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Synthesis of 1-(4-(trifluoromethyl)phenyl)-3,5-dimethyl-1H-pyrazole (ppz-3) 
 
Following the general procedure (GP2), 1-(4-(trifluoromethyl)phenyl)-3,5-dimethyl-1H-
pyrazole was obtained as a yellow oil (84%, 0.202 g). 
 
Synthesis of 1-(3-pentafluorothio)-3,5-dimethyl-1H-pyrazole (ppz-4) 
 
Following the general procedure (GP2), 1-(3-pentafluorothio)-3,5-dimethyl-1H-
pyrazole was obtained as a yellow oil (72%, 0.137 g). 
 
Synthesis of 1-(4-fluorophenyl)-3,5-dimethyl-1H-pyrazole (ppz-5) 
 
Following the general procedure (GP2), 1-(4-fluorophenyl)-3,5-dimethyl-1H-pyrazole 
was obtained as a yellow oil (57%, 0.566 g). 
 
Synthesis of 1-(4-pentafluorothio)-3,5-dimethyl-1H-pyrazole (ppz-6) 
 
Following the general procedure (GP2), 1-(4-pentafluorothio)-3,5-dimethyl-1H-
pyrazole was obtained as a yellow solid (62%, 0.186 g). 
 
General Procedure 3 (GP3): Preparation of fluorinated pyrazole-Iridium 
complexes in batch as exemplified by the synthesis of [Ir(ppz-1)2(bipy)]BF4 
 
IrCl3.xH2O (180 mg, 0.6 mmol), ppz-1 (310 mg, 1.2 mmol) and H2O (2 mL) were 
heated at reflux in 2-methoxyethanol (6 mL) under argon for 48 hours. The solution 
was cooled and H2O added (~20 mL). The resulting grey precipitate was filtered and 
oven dried to give presumed chloro-bridged dimer [Ir(ppz-1)2(μ-Cl)2(ppz-1)2]. The 
dimer [Ir(ppz-1)2(μ-Cl)2(ppz-1)2] (100 mg, 0.07 mmol) was split by stirring for 2 hours 
at reflux in the presence of AgBF4 (27 mg, 0.14 mmol) with MeCN (15 mL) as solvent. 
The solution was cooled, filtered through cotton wool and the solvent removed in 
vacuo. The crude complex was precipitated from minimal dichloromethane and 
hexane as a grey oil, [Ir(ppz-1)2(MeCN)2]BF4. The [Ir(ppz-1)2(MeCN)2]BF4 (140 mg, 
0.16 mmol) and 2,2’-bipyridine (26 mg, 0.16 mmol) were dissolved in CHCl3 (7 ml) and 
heated at reflux under argon for 24 hours. The solution was cooled and the solvent 
removed in vacuo. The crude solid was dissolved in minimal dichloromethane and 
added drop wise to stirring Et2O (15 mL) at 0°C. The resultant precipitate was filtered 
to give [Ir(ppz-1)2(bipy)]BF4 as a yellow solid (91 mg, 60%). 
1H NMR (500 MHz, CDCl3, 
25°C): δ= 8.86 (d, 3JHH = 8.2 Hz, 2H), 8.17 (t, 
3JHH  = 7.8 Hz, 2H), 7.80 (d, 
3JHH  = 5.2 
Hz, 2H), 7.41 – 7.36 (m, 4H), 6.86 (d, 3JHH  = 8.1 Hz, 2H), 6.00 (s, 2H), 5.96 (s, 2H), 
2.73 (s, 6H), 1.39 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3, 25°C): δ= 156.3, 150.2, 
149.6, 146.1, 142.6, 141.5, 140.3, 135.0, 127.9, 125.6, 124.9, 115.2, 113.2, 110.6, 
14.2, 12.0 ppm; IR (solid): n bar =  2976, 2359, 1607, 1574, 1558, 1472, 1445, 1248, 
1217, 1186, 1155, 1053, 804, 768, 664, 588, 521, 449 cm-1; UV-vis (MeCN): λmax (ε) 
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= 340 (6800) sh, 310 (18300) sh, 297 (24400), 252 nm (51000 M-1cm-1); HRMS: m/z: 
859.1786, calc. 859.1802 for [M+ - BF4].  
 
Synthesis of [Ir(ppz-2)2(bipy)]BF4 
 
Following the general procedure (GP3), with IrCl3.xH2O (156 mg, 0.53 mmol) and ppz-
2 (252 mg, 1.05 mmol). [Ir(ppz-2)2(bipy)]BF4 was isolated as a light yellow solid (130 
mg, 84%). 1H NMR (400 MHz, [D6]acetone, 25°C): δ= 8.91 (d, 3JHH = 8.2 Hz, 2H), 8.37 
(app. td, JHH = 8.0, 1.5 Hz, 2H), 8.19 (d, 
3JHH = 4.5 Hz, 2H), 7.82 (s, 2H), 7.76 – 7.70 
(m, 2H), 7.14 (d, 3JHH  = 8.1 Hz, 2H), 6.59 (d, 
3JHH  = 7.9 Hz, 2H), 6.40 (s, 2H), 2.98 
(s, 6H), 1.63 (s, 6H) ppm; 13C{1H} NMR (100 MHz, [D6]acetone, 25°C): δ= 157.5, 
152.1, 151.8, 146.0, 143.9, 141.1, 140.5, 135.1, 129.7, 125.9, 122.8 (q, JCF = 3.6 Hz), 
112.2, 110.1 (q, JCF = 4.1 Hz), 14.4, 12.4 ppm; IR (solid): n bar =  2979, 2359, 1605, 
1557, 1429, 1294,1327, 1159, 1119, 1082, 1051, 1026, 829, 772, 702; UV-vis (MeCN): 
λmax (ε) = 339 sh (4600), 310 sh (17500), 276 nm (30900 M
-1cm-1); HRMS: m/z: 
827.1887, calc. 827.1905 for [M+ - BF4].  
 
Synthesis of [Ir(ppz-3)2(bipy)]BF4 
 
Following the general procedure (GP3) with IrCl3.xH2O (151 mg, 0.5 mmol) and ppz-
3 (243 mg, 1.0 mmol). [Ir(L3)2(bipy)]BF4 was isolated as a green/yellow solid (100 mg, 
71 %). 1H NMR (400 MHz, [D6]acetone, 25°C): δ= 8.76 (d, 3JHH  = 8.2 Hz, 2H), 8.22 
(td, 3JHH  = 8.0, 1.6 Hz, 2H), 8.03 (dd, JHH  = 5.5, 0.8 Hz, 2H), 7.71 (d, 
3JHH  = 8.6 Hz, 
2H), 7.59 (ddd, 3JHH  = 7.6, 5.5, 1.2 Hz, 2H), 7.28 (dd, JHH  = 8.5, 1.4 Hz, 2H), 6.44 (d, 
3JHH  = 1.9 Hz, 2H), 6.27 (s, 2H), 2.80 (s, 6H), 1.49 (s, 6H) ppm; 
13C{1H} NMR (100 
MHz, [D6]acetone, 25°C): δ= 157.5, 152.4, 151.7, 148.5, 144.4, 141.0, 134.6, 130.1 
(q, JCF = 3.8 Hz), 127.3 (q,
 1JCF = 31.1 Hz), 125.9, 121.8 (q, JCF = 4.0 Hz), 114.2, 112.0, 
14.5, 12.4 ppm; IR (solid): n bar =  2976, 1604, 1557, 1472, 1400, 1323, 1267, 1078, 
1055, 897, 816, 767, 702, 648 cm-1; UV-vis (MeCN): λmax (ε) = 341 sh (6600), 310 sh 
(18700), 297 sh (21500), 277 nm (32400 M-1cm-1) HRMS: m/z: 827.1883, calc. 
827.1905 for [M+ - BF4].  
 
Synthesis of [Ir(ppz-4)2(bipy)]BF4 
 
Following the general procedure (GP3) with IrCl3.xH2O (122 mg, 0.4 mmol) and ppz-
4 (243 mg, 0.8 mmol). [Ir(ppz-4)2(bipy)]BF4 was isolated as an off-white solid (116 mg, 
52 %). 1H NMR (400 MHz, [D6]acetone, 25°C): δ= 8.92 (d, 3JHH = 8.0 Hz, 2H), 8.38 
(td, 3JHH = 8.0, 1.5 Hz, 2H), 8.23 (d, 
3JHH  = 4.7 Hz, 2H), 7.97 (d, 
3JHH  = 2.1 Hz, 2H), 
7.78 – 7.69 (m, 2H), 7.31 (dd, JHH  = 8.4, 2.1 Hz, 2H), 6.59 (d, 
3JHH  = 8.3 Hz, 2H), 6.42 
(s, 2H), 2.97 (s, 6H), 1.64 (s, 6H) ppm; 13C{1H} NMR (150 MHz, CD3CN, 25°C): δ= 
157.0, 152.4, 152.0, 145.5, 144.2, 140.8, 140.5, 134.4, 129.4, 125.7, 123.1, 111.8, 
111.6, 111.1, 14.4, 12.4 ppm; IR (solid): n bar =  2982, 1607, 1553, 1470, 1427, 1080, 
1051, 1035, 854, 833, 795, 771, 723, 656, 594, 567, 519 cm-1; UV-vis (MeCN): λmax 
(ε) = 342 sh (6300), 308 sh (21400), 297 sh (28300), 276 nm (36600 M-1cm-1); HRMS: 
m/z: 943.1254, calc. 943.1280 for [M+ - BF4]. 
 
Synthesis of [Ir(ppz-5)2(bipy)]BF4 
 
Following the general procedure (GP3) with IrCl3.xH2O (200 mg, 0.7 mmol) and ppz-
5 (256 mg, 1.3 mmol). [Ir(ppz-5)2(bipy)]BF4 was isolated as a yellow solid (121 mg, 56 
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%). 1H NMR (400 MHz, [D6]acetone, 25°C): δ= 8.74 (d, 3JHH = 8.1 Hz, 2H), 8.27 – 8.17 
(m, 2H), 8.06 (d, 3JHH = 4.7 Hz, 2H), 7.63 – 7.53 (m, 4H), 6.70 (td, 
3JHH  = 8.7, 2.8 Hz, 
2H), 6.16 (s, 2H), 5.83 (dd, JHH = 9.0, 2.9 Hz, 2H), 2.73 (s, 6H), 1.44 (s, 6H) ppm; 
13C{1H} NMR (100 MHz, CDCl3, 25°C): δ= 156.6, 150.0 (d, JCF = 13.7 Hz), 141.0, 
140.6, 128.0, 125.9, 120.1, 119.9, 113.8, 113.7, 110.7, 110.0, 109.7, 14.6, 12.4 ppm; 
IR (solid): n bar =  1603, 1574, 1553, 1472, 1441, 1260, 1194, 1051, 868, 814, 768, 
750, 737, 615 cm-1; UV-vis (MeCN): λmax (ε) = 341 sh (4300), 308 sh (21600), 272 nm 
(35700 M-1cm-1); HRMS: m/z: 727.1951, calc. 727.1967 for [M+ - BF4]. 
 
Synthesis of [Ir(ppz-6)2(bipy)]BF4 
 
Following the general procedure (GP3) with IrCl3.xH2O (117 mg, 0.4 mmol) and ppz-
6 (234 mg, 0.8 mmol). [Ir(ppz-6)2(bipy)]BF4 was isolated as a yellow solid (161 mg, 78 
%). 1H NMR (400 MHz, [D6]acetone, 25°C): δ= 8.78 (d, 3JHH  = 8.1 Hz, 2H), 8.27 – 
8.20 (m, 2H), 8.07 (ddd, 3JHH  = 5.5, 1.5, 0.7 Hz, 2H), 7.72 (d, 
3JHH  = 8.9 Hz, 2H), 7.61 
(ddd, 3JHH  = 7.6, 5.5, 1.2 Hz, 2H), 7.46 (dd, JHH  = 9.0, 2.6 Hz, 2H), 6.46 (d, 
3JHH  = 
2.6 Hz, 2H), 6.32 (s, 2H), 2.80 (s, 6H), 1.51 (s, 6H) ppm; 13C{1H} NMR (100 MHz, 
[D6]acetone, 25°C): δ= 157.5, 152.9, 151.8, 147.6, 144.9, 141.2, 140.2, 134.3, 130.2, 
129.7, 126.0, 122.6, 114.1, 112.2, 14.3, 12.3 ppm; IR (solid): n bar = 2971, 1470, 1439, 
1421, 1396, 1371, 1105, 1063, 1028, 839, 831, 787, 766, 725, 658, 592 cm-1; UV-vis 
(MeCN): λmax (ε) = 340 sh (6800), 310 sh (18300), 297 sh (24400), 272 nm (37100 M
-
1cm-1); HRMS: m/z: 943.1251, calc. 943.1280 for [M+ - BF4]. 
 
General Procedure 4 (GP4): Preparation of fluorinated pyrazole-Iridium 
complexes using microwave irradiation as exemplified by the synthesis of 
[Ir(ppz-1)2(bipy)]BF4 
 
IrCl3.xH2O (180 mg, 0.6 mmol), ppz-1 (310 mg, 1.2 mmol), H2O (2 mL) and 
2-methoxyethanol (6 mL) were heated in a microwave for 15 min at 180 °C. The 
solution was cooled and H2O added (~20 mL). The resulting grey precipitate was 
filtered and oven dried to give chloro-bridged dimer [Ir(ppz-1)2(μ-Cl)2(ppz-1)2]. [Ir(ppz-
1)2(μ-Cl)2(ppz-1)2] (270 mg, 0.19 mmol) was split using MeCN (5 mL) and AgBF4 (74 
mg, 0.38 mmol) heating in the microwave at 120 °C for 10 min. The solution was 
cooled, filtered through cotton wool and the solvent removed in vacuo. The crude 
complex was precipitated from minimal dichloromethane and hexane as a grey oily 
solid, [Ir(ppz-1)2(MeCN)2]BF4. [Ir(ppz-1)2(MeCN)2]BF4 (260 mg, 0.31 mmol) and 2,2’-
bipyridine (49 mg, 0.31 mmol) were dissolved in CHCl3 (7 mL) and heated in the 
microwave at 130 °C for 15 min. The solution was cooled and the solvent removed in 
vacuo. The crude solid was dissolved in minimal dichloromethane and added drop 
wise to stirring Et2O (15 mL) at 0°C. Further purification was achieved using column 
chromatography (silica) and eluting with 99:1 DCM/MeOH. The resultant precipitate 
was filtered to give [Ir(ppz-1)2(bipy)]BF4 as a yellow solid (110 mg, 40%). 
 
Synthesis of [Ir(ppz-2)2(bipy)]BF4 
 
Following the general procedure (GP4) with [Ir(ppz-2)2(MeCN)2]BF4 (42 mg, 0.050 
mmol). [Ir(ppz-2)2(bipy)]BF4 was isolated as a light yellow solid (26 mg, 57%). 
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Synthesis of [Ir(ppz-3)2(bipy)]BF4 
 
Following the general procedure (GP3) with [Ir(ppz-3)2(MeCN)2]BF4 (318 mg, 0.38 
mmol). Further purification was achieved using column chromatography (silica) and 
eluting with 99:1 DCM/MeOH. [Ir(ppz-3)2(bipy)]BF4 was isolated as a green/yellow 
solid (26 mg, 22%). 
 
Synthesis of [Ir(ppz-4)2(bipy)]BF4 
 
Following the general procedure (GP3) with [Ir(ppz-4)2(MeCN)2]BF4 (111 mg, 0.116 
mmol). [Ir(ppz-4)2(bipy)]BF4 was isolated as an off-white solid (167 mg, 76%). 
 
Synthesis of [Ir(ppz-5)2(bipy)]BF4 
 
Following the general procedure (GP3) with [Ir(ppz-5)2(MeCN)2]BF4 (50 mg, 0.067 
mmol). [Ir(ppz-5)2(bipy)]BF4 was isolated as a yellow solid (29 mg, 53%). 
 
Synthesis of [Ir(ppz-6)2(bipy)]BF4 
 
Following the general procedure (GP3) with [Ir(ppz-6)2(MeCN)2]BF4 (85 mg, 0.089 
mmol). [Ir(ppz-6)2(bipy)]BF4 was isolated as a yellow solid (64 mg, 71%). 
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Schemes	and	Figures	Legends	
	
Figure	1.	This	work:	proof	of	concept,	chemistry	model	validation	and	development	of	
synthesis	machines	1	and	2.	
	
Scheme	1.	Preparation	of	fluorinated	pyrazole	ligands	using	a	continuous	flow-microwave	
hybrid	approach.	
	
Scheme	2.	Summary	of	the	synthetic	routes	to	the	ligands	and	complexes.	
	
Scheme	3.	Structures	and	comparison	of	preparative	yields	of	the	substituted	phenyl-
pyrazole	ligands.	
	
Scheme	4.	Structures,	total	reaction	times	and	comparative	yields	(final	step)	of	the	isolated	
Ir
III
-pyrazolato	complexes.	
	
Figure	2.	Molecular	structures	of	the	iridium	complexes	(top:	[Ir(ppz-3)2(bipy)]BF4;	bottom:		
[Ir(ppz-6)2(bipy)]BF4).	Thermal	ellipsoids	drawn	at	the	30%	probability	level.	Hydrogen	
atoms,	anions	and	solvent	molecules	are	omitted	for	clarity.	
	
Figure	3:	Isosurface	plots	for	HOMO	(left)	and	LUMO	(right)	of	[Ir(ppz-5)2(bipy)]
+
,	displayed	
at	0.04	au.	
	
Figure	4.	Comparison	of	the	UV-vis.	spectra	for	the	complexes	(in	MeCN).	
	
Figure	5.	Main:	Normalised	emission	spectra	of	the	complexes	(MeCN,	lex	=	380	nm).	
Foreground:	emission	spectra	at	77K	(MeOH/EtOH	glass,	lex	=	380	nm).	
	
Figure	6.	Transient	absorption	spectra	and	data.	Left:	a	3D	time-resolved	plot	for	[Ir(ppz-
3)2(bipy)]BF4.	Right:	fitted	(red	trace)	lifetime	profiles	for	the	different	Ir
III
	complexes.	The	
lowest	panel	shows,	as	an	exemplar,	the	recovery	of	the	spectral	feature	assigned	as	a	
bleach	at	l = 310	nm	for	[Ir(ppz-3)2(bipy)]BF4.	The	recovery	of	the	bleach	occurs	on	a	
timescale	similar	to	the	decay	of	the	absorption	features	at	longer	wavelengths.	
	
Table	1.	Calculated	HOMO	and	LUMO	energies	and	%	5d	orbital	character	of	the	HOMO	for	
each	complex.	
	
Table	2	Photophysical	properties	of	the	[Ir(ppz)2(bipy)]BF4	complexes.	a)	recorded	at	RT	in	
aerated	MeCN	(lex	=	405	nm);	
b
	values	in	parentheses	were	obtained	at	77K	(1:1	
MeOH/EtOH	glass);	
c
	values	in	parentheses	are	the	lifetimes	obtained	from	time-resolved	
transient	absorption	measurements.	
	
Table	3.	Electrochemical	properties	of	the	[Ir(ppz)2(bipy)]BF4	complex.	a)	oxidation	
potentials	were	measured	as	dichloromethane	solutions	at	200	mVs
–1
	with	0.1	M	
[NBu4][PF6]	as	supporting	electrolyte	calibrated	with	Fc/Fc
+
	at	+0.46	V;	
b
	irreversible	wave;	
c
	
reversible	wave;	
d
	the	HOMO	energy	level	was	calculated	using	the	equation	–EHOMO	(eV)	=	
Eox	–	EFc/Fc+	+	4.8;	
e
	Ebandgap	was	determined	from	the	absorption	edge	of	the	iridium	
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complexes;	
f
	the	LUMO	energy	level	was	calculated	using	the	equation	ELUMO	(eV)	=	EHOMO	+	
Ebandgap	
	
	
Table	1	Calculated	HOMO	and	LUMO	energies	and	%	5d	orbital	character	of	the	HOMO	for	
each	complex.	
	
Complex	 EHOMO	/	eV	
	
ELUMO	/	eV	 EBandgap	/	eV	 %	5d	(HOMO)	
[Ir(ppz-1)2(bipy)]BF4	 -8.31	 -5.39	 2.92	 17.3	
[Ir(ppz-2)2(bipy)]BF4	 -8.46	 -5.47	 2.99	 12.5	
[Ir(ppz-3)2(bipy)]BF4	 -8.40	 -5.42	 2.98	 14.7	
[Ir(ppz-4)2(bipy)]BF4	 -8.68	 -5.59	 3.09	 21.9	
[Ir(ppz-5)2(bipy)]BF4	 -8.15	 -5.33	 2.82	 13.5	
[Ir(ppz-6)2(bipy)]BF4	 -8.61	 -5.54	 3.07	 21.8	
	
	
Table	2	Photophysical	properties	of	the	[Ir(ppz)2(bipy)]BF4	complexes.		
	
Complex	 lem	/		
nm
	[a,b]
	
τ		/		
ns
	[a,c]
	
Φem
	
[a]
	
kr	/	s
-1		
´10
6	
knr	/	s
-1		
´10
6	
[Ir(ppz-1)2(bipy)]BF4	 543	(484)	 92	(107)	 0.10	 1.09	 9.78	
[Ir(ppz-2)2(bipy)]BF4	 528	(488)	 109	(113)	 0.15	 1.37	 7.80	
[Ir(ppz-3)2(bipy)]BF4	 537	(484)	 101	(103)	 0.11	 1.09	 8.81	
[Ir(ppz-4)2(bipy)]BF4	 516	(484)	 123	(133)	 0.19	 1.54	 6.59	
[Ir(ppz-5)2(bipy)]BF4	 557	(497)	 77	(90)	 0.05	 0.65	 12.34	
[Ir(ppz-6)2(bipy)]BF4	 520	(485)	 112	(127)	 0.15	 1.34	 7.59	
a
	recorded	at	RT	in	aerated	MeCN	(lex	=	405	nm);	
b
	values	in	parentheses	were	obtained	at	
77K	(1:1	MeOH/EtOH	glass);	
c
	values	in	parentheses	are	the	lifetimes	obtained	from	time-
resolved	transient	absorption	measurements.	
	
	
	
Table	3	Electrochemical	properties	of	the	[Ir(ppz)2(bipy)]BF4	complex.		
	
Complex
	
	 Eox	/	V
[a]
	 Ered	/	V
[a]
	 HOMO	/	eV
	
[d]
	
LUMO	/	eV
[f]
	 Ebandgap	/	
eV
[e]
	
[Ir(ppz-1)2(bipy)]BF4	 +1.62
[b]
	 -1.33
[b]
	 -5.96	 -3.43	 2.53	
[Ir(ppz-2)2(bipy)]BF4	 +1.66
[b]
	 -1.32
[c]
	 -6.00	 -3.44	 2.56	
[Ir(ppz-3)2(bipy)]BF4	 +1.60
[c]
	 -1.35
[c]
	 -5.94	 -3.39	 2.55	
[Ir(ppz-4)2(bipy)]BF4	 +1.74
[b]
	 -1.30
[c]
	 -6.08	 -3.52	 2.56	
[Ir(ppz-5)2(bipy)]BF4	 +1.47
[c]
	 -1.47
[b]
	 -5.81	 -3.30	 2.51	
[Ir(ppz-6)2(bipy)]BF4	 +1.75
[b]
	 -1.30
[b]
	 -6.09	 -3.47	 2.62	
a
	oxidation	potentials	were	measured	as	dichloromethane	solutions	at	200	mVs
–1
	with	0.1	M	
[NBu4][PF6]	as	supporting	electrolyte	calibrated	with	Fc/Fc
+
	at	+0.46	V;	
b
	irreversible	wave;	
c
	
reversible	wave;	
d
	the	HOMO	energy	level	was	calculated	using	the	equation	–EHOMO	(eV)	=	
Eox	–	EFc/Fc+	+	4.8;	
e
	Ebandgap	was	determined	from	the	absorption	edge	of	the	iridium	
complexes;	
f
	the	LUMO	energy	level	was	calculated	using	the	equation	ELUMO	(eV)	=	EHOMO	+	
Ebandgap	
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Synthesis	machines	can	rapidly	produce	novel	iridium-based	phosphors	with	tuneable	
luminescence	and	redox	properties.	
	
